Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.

Gingo MR, Balasubramani GK, Kingsley L, Rinaldo CR Jr, Alden CB, Detels R, Greenblatt RM, Hessol NA, Holman S, Huang L, Kleerup EC, Phair J, Sutton SH, Seaberg EC, Margolick JB, Wisniewski SR, Morris A.

PLoS One. 2013;8(3):e58812. doi: 10.1371/journal.pone.0058812. Epub 2013 Mar 12.

2.

Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts.

Gingo MR, Balasubramani GK, Rice TB, Kingsley L, Kleerup EC, Detels R, Seaberg EC, Greenblatt RM, Holman S, Huang L, Sutton SH, Bertolet M, Morris A.

BMC Pulm Med. 2014 Apr 30;14:75. doi: 10.1186/1471-2466-14-75.

3.
4.

Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.

Hessol NA, Kalinowski A, Benning L, Mullen J, Young M, Palella F, Anastos K, Detels R, Cohen MH.

Clin Infect Dis. 2007 Jan 15;44(2):287-94. Epub 2006 Dec 12.

5.

Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.

Falade-Nwulia O, Seaberg EC, Snider AE, Rinaldo CR, Phair J, Witt MD, Thio CL.

Ann Intern Med. 2015 Nov 3;163(9):673-80. doi: 10.7326/M15-0547. Epub 2015 Oct 13.

6.

HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study.

Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, Anastos K, Minkoff H, Orenstein J, Dominguez G, Watts DH.

J Clin Oncol. 2010 Mar 20;28(9):1514-9. doi: 10.1200/JCO.2009.25.6149. Epub 2010 Feb 22.

7.

Cancer risk among participants in the women's interagency HIV study.

Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, Melnick S, Abulafia O, Levine AM; WIHS Collaborative Study Group.

J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):978-85.

PMID:
15220706
8.

Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.

Palella FJ Jr, Gange SJ, Benning L, Jacobson L, Kaplan RC, Landay AL, Tracy RP, Elion R.

AIDS. 2010 Jul 17;24(11):1657-65. doi: 10.1097/QAD.0b013e3283389dfa.

9.

Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.

Kohli R, Lo Y, Howard AA, Buono D, Floris-Moore M, Klein RS, Schoenbaum EE.

Clin Infect Dis. 2005 Sep 15;41(6):864-72. Epub 2005 Aug 16.

10.

Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.

Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP; Multicenter AIDS Cohort Study (MACS).

Cancer. 2010 Dec 1;116(23):5507-16. doi: 10.1002/cncr.25530. Epub 2010 Jul 29.

11.

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.

Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, Dehovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, Gange SJ.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):217-20. doi: 10.1097/QAI.0b013e3181e674f4.

12.

Lung cancer incidence and survival among HIV-infected and uninfected women and men.

Hessol NA, Martínez-Maza O, Levine AM, Morris A, Margolick JB, Cohen MH, Jacobson LP, Seaberg EC.

AIDS. 2015 Jun 19;29(10):1183-93. doi: 10.1097/QAD.0000000000000690.

13.

Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort.

Gingo MR, Zhang Y, Ghebrehawariat KB, Jeong JH, Chu Y, Yang Q, Lucht L, Hanna DB, Lazar JM, Gladwin MT, Morris A.

PLoS One. 2015 Mar 26;10(3):e0123389. doi: 10.1371/journal.pone.0123389. eCollection 2015.

14.

Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.

Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-52.

PMID:
15385731
15.

Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study.

Sharma A, Hoover DR, Shi Q, Gustafson D, Plankey MW, Hershow RC, Tien PC, Golub ET, Anastos K.

PLoS One. 2015 Dec 23;10(12):e0143740. doi: 10.1371/journal.pone.0143740. eCollection 2015.

16.

HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.

Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC, Oursler KK, Rimland D, Gibert CL, Butt AA, Justice AC.

Am J Respir Crit Care Med. 2011 Feb 1;183(3):388-95. doi: 10.1164/rccm.201006-0836OC. Epub 2010 Sep 17.

17.

Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.

Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, Yang SY.

HIV Med. 2008 Aug;9(7):535-43. doi: 10.1111/j.1468-1293.2008.00600.x. Epub 2008 Jun 28.

18.

Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.

Atta MG, Fine DM, Kirk GD, Mehta SH, Moore RD, Lucas GM.

Clin Infect Dis. 2007 Dec 15;45(12):1625-32. doi: 10.1086/523728. Erratum in: Clin Infect Dis. 2008 Feb 1;46(3):488.

19.

Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.

Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG.

AIDS. 2012 Mar 13;26(5):599-607. doi: 10.1097/QAD.0b013e32834fa121.

20.

Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.

Murphy K, Hoover DR, Shi Q, Cohen M, Gandhi M, Golub ET, Gustafson DR, Pearce CL, Young M, Anastos K.

AIDS. 2013 Sep 24;27(15):2413-23. doi: 10.1097/01.aids.0000432537.92958.73.

Items per page

Supplemental Content

Write to the Help Desk